Edition:
United Kingdom

Aralez Pharmaceuticals Inc (ARLZ.OQ)

ARLZ.OQ on NASDAQ Stock Exchange Global Select Market

1.39USD
20 Apr 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.39
Open
$1.41
Day's High
$1.41
Day's Low
$1.37
Volume
11,162
Avg. Vol
99,767
52-wk High
$2.98
52-wk Low
$0.95

Select another date:

Thu, Apr 5 2018

BRIEF-Aralez Pharmaceuticals Says Unit Entered Into Modification Of Contract

* ARALEZ PHARMA - UNIT ENTERED INTO MODIFICATION OF CONTRACT PURSUANT TO WHICH U.S. EXERCISED SECOND RENEWAL OPTION UNDER THAT VA NATIONAL CONTRACT

BRIEF-Aralez Pharmaceuticals Inc - ‍On March 13, Board Appointed Michael Kaseta As Company's CFO - SEC Filing

* ARALEZ PHARMACEUTICALS INC - ‍ON MARCH 13, BOARD APPOINTED MICHAEL KASETA AS COMPANY'S CFO - SEC FILING Source text (http://bit.ly/2p8Z0x1) Further company coverage: (Reuters.Brief@thomsonreuters.com)

BRIEF-Aralez Pharmaceuticals Posts Q4 Loss Per Share $0.68‍‍​

* ARALEZ ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS

BRIEF-Aralez Pharmaceuticals files for mixed shelf offering of up to $100 mln - SEC filing‍​

* Aralez Pharmaceuticals Inc - files for mixed shelf offering of up to $100 million - SEC filing‍​ Source text: (http://bit.ly/2zrTHPn) Further company coverage:

BRIEF-Aralez sees 2018 net revenues $140 mln to $160 mln‍​

* Aralez announces third quarter 2017 financial results and achieves profitability on an adjusted EBITDA basis for the first time in the third quarter

Select another date: